A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

IsraelRecruitingPHASE1, PHASE2

Conditions

Malignant Neoplasm

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Childrens Hospital Los Angeles ( Site 3006), Los Angeles, California, United States

    Study coordinator · 323-361-2121
  • Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 3016), Aurora, Colorado, United States

    Study coordinator · 720-777-1234
  • Yale New Haven Hospital ( Site 3012), New Haven, Connecticut, United States

    Study coordinator · 203-785-4640
  • Johns Hopkins All Children's Hospital ( Site 3025), St. Petersburg, Florida, United States

    Study coordinator · 727-767-4176
  • University of Iowa Health Care Holden Comprehensive Cancer Center ( Site 3017), Iowa City, Iowa, United States

    Study coordinator · 319-356-2296
  • Dana-Farber Cancer Institute ( Site 3013), Boston, Massachusetts, United States

    Study coordinator · 617-632-4580
  • Corewell Health ( Site 3001), Grand Rapids, Michigan, United States

    Study coordinator · 616-486-0746
  • Children's Mercy Hospital ( Site 3024), Kansas City, Missouri, United States

    Study coordinator · 816-302-6808
  • Rutgers Cancer Institute of New Jersey ( Site 3008), New Brunswick, New Jersey, United States

    Study coordinator · 732-235-2465
  • Memorial Sloan Kettering Cancer Center ( Site 3010), New York, New York, United States

    Study coordinator · 888-492-8401
  • New York Medical College ( Site 3023), Valhalla, New York, United States

    Study coordinator · 914-614-4270
  • Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 3003), Fargo, North Dakota, United States

    Study coordinator · 701-234-2000
  • Oregon Health and Science University ( Site 3004), Portland, Oregon, United States

    Study coordinator · 503-494-8311
  • Children's Hospital of Philadelphia (CHOP) ( Site 3021), Philadelphia, Pennsylvania, United States

    Study coordinator · 267-425-5544
  • Sanford Children's Hospital ( Site 3015), Sioux Falls, South Dakota, United States

    Study coordinator · 605-312-1000
  • University of Texas-MD Anderson Cancer Center ( Site 3007), Houston, Texas, United States

    Study coordinator · 713-792-5410
  • Intermountain - Primary Children's Hospital ( Site 3014), Salt Lake City, Utah, United States

    Study coordinator · 801-662-4700
  • Sydney Children's Hospital-Kids Cancer Centre ( Site 3997), Sydney, New South Wales, Australia

    Study coordinator · 61293821111
  • Queensland Children's Hospital ( Site 3996), Brisbane, Queensland, Australia

    Study coordinator · 61730681111
  • UZ Gent ( Site 3428), Ghent, Oost-Vlaanderen, Belgium

    Study coordinator · +3293324812
  • Hospital de Clinicas de Porto Alegre ( Site 3265), Porto Alegre, Rio Grande do Sul, Brazil

    Study coordinator · +5551980139616
  • Fundação Pio XII - Hospital de Câncer de Barretos ( Site 3264), Barretos, São Paulo, Brazil

    Study coordinator · +551733216638
  • Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 3267), São José do Rio Preto, São Paulo, Brazil

    Study coordinator · +55 17 99625-3919
  • The Hospital for Sick Children ( Site 3225), Toronto, Ontario, Canada

    Study coordinator · 4168131500
  • Hospital Carlos Van Buren ( Site 3880), Valparaíso, Valparaiso, Chile

    Study coordinator · 56978546125
  • Hospital Pablo Tobon Uribe ( Site 3923), Medellín, Antioquia, Colombia

    Study coordinator · +57 3006523572
  • Clinica de la Costa S.A.S. ( Site 3924), Barranquilla, Atlántico, Colombia

    Study coordinator · +573008096054
  • IMAT S.A.S ( Site 3921), Montería, Departamento de Córdoba, Colombia

    Study coordinator · +576047862333
  • Detska nemocnice FN Brno ( Site 3388), Brno, Brno-mesto, Czechia

    Study coordinator · +420532234755
  • Fakultni nemocnice v Motole-Klinika detske hematologie a onkologie ( Site 3387), Prague, Praha 5, Czechia

    Study coordinator · +420224436475
  • Rigshospitalet-Department of paediatrics and adolescent medicine, Section of Paed haem-onc ( Site 3467), Copenhagen, Capital Region, Denmark

    Study coordinator · +4535452462
  • Bordeaux University Hospital - Pellegrin ( Site 3105), Bordeaux, Aquitaine, France

    Study coordinator · +33556795679
  • Assistance Publique Hôpitaux de Marseille - Hôpital de la Timone ( Site 3102), Marseille, Bouches-du-Rhone, France

    Study coordinator · +33491385238
  • Centre Hospitalier Universitaire de Nantes - Hôpital Femme-Enfant-Adolescent Chu De Nantes ( Site 3104), Nantes, Loire-Atlantique, France

    Study coordinator · +33240083610
  • Centre Leon-Berard ( Site 3100), Lyon, Rhone, France

    Study coordinator · 33469166572
  • Institut Curie ( Site 3101), Paris, Île-de-France Region, France

    Study coordinator · +33144324015
  • Universitätsklinikum Münster - Albert Schweitzer Campus ( Site 3141), Münster, North Rhine-Westphalia, Germany

    Study coordinator · +492518347742
  • Aghia Sophia Children's Hospital-First Department of Pediatrics, National and Kapodistrian Universi ( Site 3797), Athens, Attica, Greece

    Study coordinator · +302107452125
  • Semmelweis University ( Site 3838), Budapest, Pest County, Hungary

    Study coordinator · +3612151380
  • Rambam Health Care Campus ( Site 3674), Haifa, Israel

    Study coordinator · 97247774718
  • Sheba Medical Center ( Site 3675), Ramat Gan, Israel

    Study coordinator · +97235302996
  • Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 3552), Milan, Italy

    Study coordinator · 00390223902593
  • Ospedale Pediatrico Bambino Gesù IRCCS ( Site 3553), Roma, Italy

    Study coordinator · 00390668593697
  • Ospedale Infantile Regina Margherita ( Site 3551), Torino, Italy

    Study coordinator · 00390113135230
  • Prinses Maxima Centrum voor Kinderoncologie ( Site 3510), Utrecht, Netherlands

    Study coordinator · +31889727272
  • Narodny ustav detskych chorob ( Site 3592), Bratislava, Bratislava Region, Slovakia

    Study coordinator · +421259371205
  • Seoul National University Hospital-Pediatrics ( Site 3972), Seoul, South Korea

    Study coordinator · +82220723304
  • Asan Medical Center-Pediatrics - Pedicatric Oncology ( Site 3973), Seoul, South Korea

    Study coordinator · +82230105994
  • Hospital Sant Joan de Déu ( Site 3717), Esplugues de Llobregat, Barcelona, Spain

    Study coordinator · +34671600093
  • Hospital Universitari Vall d''Hebron ( Site 3716), Barcelona, Spain

    Study coordinator · +34915035900x662
  • Hospital Infantil Universitario Nino Jesus ( Site 3715), Madrid, Spain

    Study coordinator · +34915035900
  • Sahlgrenska Universitetssjukhuset ( Site 3634), Gothenburg, Västra Götaland County, Sweden

    Study coordinator · +46313435865
  • National Taiwan University Hospital ( Site 3983), Taiwan, Taipei, Taiwan

    Study coordinator · 8862-23123456#70559
  • Hacettepe Universitesi Tip Fakultesi Hastanesi ( Site 3961), Ankara, Turkey (Türkiye)

    Study coordinator · +90 312 305 50 00
  • Ankara Bilkent Şehir Hastanesi. ( Site 3962), Ankara, Turkey (Türkiye)

    Study coordinator · +90 312 552 60 00
  • Ege Universitesi Hastanesi ( Site 3963), Izmir, Turkey (Türkiye)

    Study coordinator · +905301469380
  • Birmingham Children's Hospital ( Site 3349), Birmingham, England, United Kingdom

    Study coordinator · +441213338233
  • Royal Victoria Infirmary ( Site 3348), Newcastle upon Tyne, England, United Kingdom

    Study coordinator · 0191 282 1014
  • University Hospital of Wales ( Site 3346), Cardiff, United Kingdom

    Study coordinator · +4402921842107
  • Royal Marsden Hospital ( Site 3347), Sutton, United Kingdom

    Study coordinator · 020 8642 6011
Study leads
  • Medical Director

    Study Director

    Merck Sharp & Dohme LLC